Detalhe da pesquisa
1.
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
Br J Haematol
; 200(3): 306-314, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261137
2.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257914
3.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Br J Haematol
; 202(4): 776-784, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386877
4.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320921
5.
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study.
J Med Internet Res
; 24(8): e37368, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943786
6.
Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease.
Blood
; 133(25): 2664-2668, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010846
7.
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
Eur J Haematol
; 106(6): 842-850, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713387
8.
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
Br J Haematol
; 185(3): 480-491, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793290
9.
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Blood
; 138(19): 1901-1905, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329372
10.
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 97(5): 923, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473097
11.
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 97(5): 763-772, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29392425
12.
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
Biol Blood Marrow Transplant
; 23(10): 1631-1640, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533060
13.
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
Br J Haematol
; 178(5): 699-708, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782811
14.
Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.
J Oncol Pharm Pract
; : 1078155217743069, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207936
15.
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.
Leuk Lymphoma
; 65(1): 14-25, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840282
16.
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.
Cancers (Basel)
; 16(7)2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610963
17.
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
Br J Haematol
; 161(5): 667-676, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23560534
18.
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment.
Hematol Oncol
; 36(5): 765-772, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129233
19.
Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting.
Clin Transl Sci
; 16(2): 305-312, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385738
20.
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure.
Life (Basel)
; 13(9)2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37763245